文献速递免疫规划卫生政策与健康促进

阿肯色州居民5年流感疫苗接种与社会人口学因素及医疗可及性的关联

Associations between 5-year influenza vaccination and sociodemographic factors and healthcare access among Arkansans.
PubMed 文献 · Vaccine · 2022-05-20

本研究基于全州大型随机样本,分析阿肯色州居民5年流感疫苗接种率与社会人口学特征、疫苗犹豫及医疗可及性指标的关系。结果显示,较高年龄、女性、西班牙裔、本科及以上学历、拥有初级保健提供者、过去两年内进行医生检查以及无疫苗犹豫是接种流感疫苗的显著预测因素。

要点

  • 较高年龄、女性、西班牙裔、本科及以上学历与接种流感疫苗显著相关。
  • 拥有初级保健提供者、过去两年内医生检查及无疫苗犹豫是显著预测因素。
  • 医疗可及性指标(如保险、因费用放弃医疗)未在摘要中报告为显著预测因素。

核心结论

  • 较高年龄、女性、西班牙裔、本科及以上学历、拥有初级保健提供者、过去两年内医生检查及无疫苗犹豫是接种流感疫苗的显著预测因素。

研究设计与样本

  • 研究采用全州大型随机样本,分析阿肯色州居民5年流感疫苗接种情况。

主要发现

  • 2020-2021流感季美国成人流感疫苗接种率为50.2%,阿肯色州成人为50.3%。
  • 较高年龄、女性、西班牙裔、本科及以上学历、拥有初级保健提供者、过去两年内医生检查及无疫苗犹豫是接种流感疫苗的显著预测因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite wide availability, only 50.2% of the United States (US) adult population and 50.3% of adult Arkansans were vaccinated for influenza during the 2020-2021 influenza season. The proportion of the population vaccinated for influenza varies by age, sex, race/ethnicity, education, rural/urban residence, and income. However, measures of healthcare access have not been adequately investigated as predictors of influenza vaccination. Using a large, statewide random sample, this study examined 5-year influenza vaccination among Arkansans by sociodemographic characteristics (age, sex, race/ethnicity, education, rural/urban residence), general vaccine hesitancy, and healthcare access (having a primary care provider, having health insurance, forgoing health care due to cost, and frequency of doctor checkups). Older age, being female, being Hispanic, having a bachelor's degree or higher, having a primary care provider, visiting a doctor for a checkup in the past two years, and lack of hesitancy towards vaccines were significant predictors of receiving influenza vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. McElfish PA, Selig JP, Scott AJ, et al. Associations between 5-year influenza vaccination and sociodemographic factors and healthcare access among Arkansans. Vaccine. 2022. PMID: 35606233. doi:10.1016/j.vaccine.2022.05.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。